Julia Dunn

Company: Eli Lily

Job title: Executive Director - Medical

Seminars:

From “Treat to Target” to Tailored Treatment: Leveraging Clinical Insights with Eli Lilly’s Novel Therapies to Personalize Obesity Care 10:00 am

Implementing a “Treat to Target” strategy allows clinicians to use data-driven insights for personalization, which results in more effective and proactive patient care Leveraging next-generation therapies from Eli Lilly provides new opportunities to reach specific treatment goals for individual patients, ultimately leading to clinically meaningful and sustained health improvements This paradigm shift in obesity management…Read more

day: Day Two

Roundtable Discussion: Discovering Genetic Predispositions for Personalized Intervention Strategies to Identify High-Risk Individuals for Preventative & Targeted Treatments 2:30 pm

Utilizing polygenic risk scores for assessing individual susceptibility to predict obesity development for early intervention strategies Identifying monogenic obesity genes for precise diagnosis and treatment selection to enable targeted therapies for improved patient outcomes Applying pharmacogenomics for predicting drug response and side effect profiles to personalize medication choices for optimized therapeutic efficacy and safetyRead more

day: Pre-Conference Day